接受GINA 1-3级治疗仍未控制哮喘患者的可治疗特征与急性加重风险
未控制与女性、年龄、低教育程度及吸烟、肥胖、心血管病、抑郁/焦虑等可治疗特征相关,并与未来口服糖皮质激素使用和哮喘住院风险升高相关。
要点
- GINA 1-3级治疗患者中超过半数哮喘未控制,应重视可治疗特征评估。
- 吸烟、肥胖、心血管病及抑郁/焦虑与未控制哮喘及未来急性加重风险升高相关。
- 对轻中度哮喘患者需整体评估并管理可治疗特征以降低未来急性加重风险。
核心结论
- GINA 1-3级治疗的轻中度哮喘患者中超过50%未控制,吸烟、肥胖及共病等可治疗特征与未控制及未来急性加重风险升高相关。
研究设计与样本
- 按GINA分为1-3级与4-5级治疗,依据症状控制、急性加重和肺功能定义未控制哮喘。
主要发现
- GINA 1-3级治疗者17318例,其中9586例(55%)为未控制哮喘(UCA 1-3)。
- 调整分析中UCA 1-3与女性(OR 1.34,95%CI 1.27-1.41)、小学教育(1.30,1.20-1.40)、中学教育(1.19,1.12-1.26)相关。
- UCA 1-3与吸烟(1.25,1.15-1.36)、肥胖(1.23,1.15-1.32)、心血管病(1.12,1.06-1.20)、抑郁/焦虑(1.13,1.06-1.21)相关。
- UCA 1-3与未来口服糖皮质激素使用(1.90,1.74-2.09)及哮喘住院(2.55,2.17-3.00)相关,调整4-5级治疗后仍存在。
临床怎么用
- 对GINA 1-3级治疗仍未控制的哮喘患者,应整体评估并管理吸烟、肥胖及共病等可治疗特征。
- 识别上述可治疗特征有助于判断未来急性加重风险较高的人群并加强随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Uncontrolled asthma in patients treated for mild/moderate disease could be caused by non-pulmonary treatable traits (TTs) that affect asthma control negatively. We aimed to identify demographic characteristics, behavioural (smoking) and extrapulmonary (obesity, comorbidities) TTs and the risk for future exacerbations among patients with uncontrolled asthma prescribed step 1-3 treatment according to the Global Initiative for Asthma (GINA). METHODS: Twenty-eight thousand five hundred eighty-four asthma patients (≥18 y) with a registration in the Swedish National Airway Register between 2017 and 2019 were included (index-date). The database was linked to other national registers to obtain information on prescribed drugs 2-years pre-index and exacerbations 1-year post-index. Asthma treatment was classified into step 1-3 or 4-5, and uncontrolled asthma was defined based on symptom control, exacerbations and lung function. RESULTS: GINA step 1-3 included 17,318 patients, of which 9586 (55%) were uncontrolled (UCA 1-3). In adjusted analyses, UCA 1-3 was associated with female sex (OR 1.34, 95% CI 1.27-1.41), older age (1.00, 1.00-1.00), primary education (1.30, 1.20-1.40) and secondary education (1.19, 1.12-1.26), and TTs such as smoking (1.25, 1.15-1.36), obesity (1.23, 1.15-1.32), cardiovascular disease (1.12, 1.06-1.20) and depression/anxiety (1.13, 1.06-1.21). Furthermore, UCA 1-3 was associated with future exacerbations; oral corticosteroids (1.90, 1.74-2.09) and asthma hospitalization (2.55, 2.17-3.00), respectively, also when adjusted for treatment step 4-5. CONCLUSION: Over 50% of patients treated for mild/moderate asthma had an uncontrolled disease. Assessing and managing of TTs such as smoking, obesity and comorbidities should be conducted in a holistic manner, as these patients have an increased risk for future exacerbations.
引用
- Konradsen, Selberg, Ödling, et al. Treatable traits and exacerbation risk in patients with uncontrolled asthma prescribed GINA step 1-3 treatment: A nationwide asthma cohort study. Respirology. 2024. PMID: 38859634. doi:10.1111/resp.14774
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。